Cross-regulation Between Micrornas and Key Proteins of Signaling Pathways in Hepatocellular Carcinoma
Haihong Hu,Tao-Lan Zhang,Yiwen Wu,Meina Deng,Huiling Deng,Xiaoyan Yang
DOI: https://doi.org/10.1080/17474124.2022.2101994
2022-01-01
Expert Review of Gastroenterology & Hepatology
Abstract:ABSTRACT Introduction Hepatocellular carcinoma (HCC) is a subtype of primary liver cancer and a major cause of death. Although miRNA plays an important role in hepatocellular carcinoma, the specific regulatory network remains unclear. Therefore, this paper comprehensively describes the miRNA-related signaling pathways in HCC and the possible interactions among different signaling pathways. The aim is to lay the foundation for the discovery of new molecular targets and multi-target therapy. Areas covered Based on miRNA, HCC, and signaling pathways, the literature was searched on Web of Science and PubMed. Then, common targets between different signaling pathways were found from KEGG database, and possible cross-regulation mechanisms were further studied. In this review, we elaborated from two aspects, respectively, laying a foundation for studying the regulatory mechanism and potential targets of miRNA in HCC. Expert opinion Non-coding RNAs have become notable molecules in cancer research in recent years, and many types of targeted drugs have emerged. From the outset, molecular targets and signal pathways are interlinked, which suggests that signal pathways and regulatory networks should be concerned in basic research, which also provides a strong direction for future mechanism research.